Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bacterial live therapeutics for human diseases

23 Oct 2024

Abstract excerpt

The genomic revolution has fueled rapid progress in synthetic and systems biology, opening up new possibilities for using live biotherapeutic products (LBP) to treat, attenuate or prevent human diseases. Among LBP, bacteria-based therapies are particularly promising due to their ability to colonize diverse human tissues, modulate the immune system and secrete or deliver complex biological products. These...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Research and Treatments
Share to Clostridium difficile and Clostridium perfringens research
Share to Gut microbiota and health

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39443745
DOI: 10.1038/s44320-024-00067-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bacterial live therapeutics for human diseasesPMID 39443745Read ↗

Recent advances in single-cell engineered live biotherapeutic products research for skin repair and disease treatmentSemantic proximity Read ↗

Perspectives on Microbiome Therapeutics in Infectious Diseases: A Comprehensive Approach beyond Immunology and MicrobiologySemantic proximity Read ↗

Beyond killingSemantic proximity Read ↗

Advancing vaccine technology through the manipulation of pathogenic and commensal bacteriaSemantic proximity Read ↗

Synthetic consortia of nanobody‐coupled and formatted bacteria for prophylaxis and therapy interventions targeting microbiome dysbiosis‐associated diseases and co‐morbiditiesSemantic proximity Read ↗

Genetically engineered bacteria as inflammatory bowel disease therapeuticsSemantic proximity Read ↗

Advancements in Novel Live Biotherapeutic Products for Clostridioides difficile Infection PreventionSemantic proximity Read ↗

Probiotics, their action modality and the use of multi-omics in metamorphosis of commensal microbiota into target-based probioticsSemantic proximity Read ↗

Genetically engineered bacterium: Principles, practices, and prospectsSemantic proximity Read ↗

Bioengineered microbes in disease therapySemantic proximity Read ↗

Investiture of next generation probiotics on amelioration of diseases – Strains do matterSemantic proximity Read ↗

Bacteriophage-mediated modulation of microbiota for diseases treatmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.